{"example_id": "1364-00", "context": "Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol) was dissolved in methanol (50 mL).Under the protection of nitrogen gas, Pd/C (1.3 g) was added to the system.", "anaphor": "the system", "gold_antecedents": ["Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol)", "methanol (50 mL)"], "preceding_anaphors": []}
{"example_id": "1364-01", "context": "Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol) was dissolved in methanol (50 mL).Under the protection of nitrogen gas, Pd/C (1.3 g) was added to the system. At the atmosphere of hydrogen gas, the resultant mixture.", "anaphor": "the resultant mixture", "gold_antecedents": ["Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol)", "methanol (50 mL)", "nitrogen gas", "Pd/C (1.3 g)", "the atmosphere of hydrogen gas"], "preceding_anaphors": ["the system"]}
{"example_id": "1364-02", "context": "Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol) was dissolved in methanol (50 mL).Under the protection of nitrogen gas, Pd/C (1.3 g) was added to the system. At the atmosphere of hydrogen gas, the resultant mixture was reacted at room temperature under stirring for 16h. After the reaction, the resultant mixture.", "anaphor": "the resultant mixture", "gold_antecedents": ["Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol)", "methanol (50 mL)", "nitrogen gas", "Pd/C (1.3 g)", "the atmosphere of hydrogen gas"], "preceding_anaphors": ["the system", "the resultant mixture"]}
{"example_id": "1364-03", "context": "Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol) was dissolved in methanol (50 mL).Under the protection of nitrogen gas, Pd/C (1.3 g) was added to the system. At the atmosphere of hydrogen gas, the resultant mixture was reacted at room temperature under stirring for 16h. After the reaction, the resultant mixture was filtrated and concentrated to obtain the product (800mg, yield: 76%).", "anaphor": "the product (800mg, yield: 76%)", "gold_antecedents": ["Tert-butyl4-(7-amino-6-bromo-5-methylbenzo[d][1,3]dioxol-4-yl)-3,6-di hydropyridine-1(2H)-carboxylate (1.3 g, 3.16 mmol)", "methanol (50 mL)", "nitrogen gas", "Pd/C (1.3 g)", "the atmosphere of hydrogen gas"], "preceding_anaphors": ["the system", "the resultant mixture", "the resultant mixture"]}
{"example_id": "1391-00", "context": "Analogous to the process for preparing Compound (1) in Step 7 in Example 1, Compound v was condensed with Compound f to produce Compound (7).", "anaphor": "Compound (7)", "gold_antecedents": ["Compound v", "Compound f"], "preceding_anaphors": []}
{"example_id": "0453-00", "context": "10.073 g (59.04 mmol) of 2-chloro-6-methylbenzoic acid was mixed with anhydrous dichloromethane (150 mL), to which 10.3 ml (118.09 mmol, 2 equivalents) of oxalylchloride was added. Dimethylformamide was dropped thereto 1-2 drops, and the mixture.", "anaphor": "the mixture", "gold_antecedents": ["10.073 g (59.04 mmol) of 2-chloro-6-methylbenzoic acid", "anhydrous dichloromethane (150 mL)", "10.3 ml (118.09 mmol, 2 equivalents) of oxalylchloride"], "preceding_anaphors": []}
{"example_id": "0453-01", "context": "10.073 g (59.04 mmol) of 2-chloro-6-methylbenzoic acid was mixed with anhydrous dichloromethane (150 mL), to which 10.3 ml (118.09 mmol, 2 equivalents) of oxalylchloride was added. Dimethylformamide was dropped thereto 1-2 drops, and the mixture was stirred at room temperature for 4 hours. The mixture.", "anaphor": "The mixture", "gold_antecedents": ["10.073 g (59.04 mmol) of 2-chloro-6-methylbenzoic acid", "anhydrous dichloromethane (150 mL)", "10.3 ml (118.09 mmol, 2 equivalents) of oxalylchloride"], "preceding_anaphors": ["the mixture"]}
{"example_id": "0453-02", "context": "10.073 g (59.04 mmol) of 2-chloro-6-methylbenzoic acid was mixed with anhydrous dichloromethane (150 mL), to which 10.3 ml (118.09 mmol, 2 equivalents) of oxalylchloride was added. Dimethylformamide was dropped thereto 1-2 drops, and the mixture was stirred at room temperature for 4 hours. The mixture was concentrated under reduced pressure. As a result, 11.479 g of the target compound brown liquid target compound 2-chloro-6-methylbenzoyl chloride was obtained as a brown liquid.", "anaphor": "a brown liquid", "gold_antecedents": ["2-chloro-6-methylbenzoyl chloride"], "preceding_anaphors": ["the mixture", "The mixture"]}
{"example_id": "0102-00", "context": "182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 105 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide. The reaction mixture.", "anaphor": "The reaction mixture", "gold_antecedents": ["182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "105 mg (1 mmol) of 1-oxy-pyridin-2-ol", "a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide"], "preceding_anaphors": []}
{"example_id": "0102-01", "context": "182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 105 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide. The reaction mixture is stirred for 5 min and then 253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one and 0.15 mL (1 mmol) of triethylamine are added. The reaction mixture.", "anaphor": "The reaction mixture", "gold_antecedents": ["182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "105 mg (1 mmol) of 1-oxy-pyridin-2-ol", "a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide", "253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one", "0.15 mL (1 mmol) of triethylamine"], "preceding_anaphors": ["The reaction mixture"]}
{"example_id": "0102-02", "context": "182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 105 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide. The reaction mixture is stirred for 5 min and then 253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one and 0.15 mL (1 mmol) of triethylamine are added. The reaction mixture is stirred at room temperature for 12 hours, then diluted with dichloromethane and water. The aqueous phase.", "anaphor": "The aqueous phase", "gold_antecedents": ["182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "105 mg (1 mmol) of 1-oxy-pyridin-2-ol", "a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide", "253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one", "0.15 mL (1 mmol) of triethylamine", "dichloromethane", "water"], "preceding_anaphors": ["The reaction mixture", "The reaction mixture"]}
{"example_id": "0102-03", "context": "182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 105 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide. The reaction mixture is stirred for 5 min and then 253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one and 0.15 mL (1 mmol) of triethylamine are added. The reaction mixture is stirred at room temperature for 12 hours, then diluted with dichloromethane and water. The aqueous phase is extracted three times with dichloromethane, the organic phases.", "anaphor": "the organic phases", "gold_antecedents": ["182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "105 mg (1 mmol) of 1-oxy-pyridin-2-ol", "a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide", "253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one", "0.15 mL (1 mmol) of triethylamine", "dichloromethane", "water", "dichloromethane"], "preceding_anaphors": ["The reaction mixture", "The reaction mixture", "The aqueous phase"]}
{"example_id": "0102-04", "context": "182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 105 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide. The reaction mixture is stirred for 5 min and then 253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one and 0.15 mL (1 mmol) of triethylamine are added. The reaction mixture is stirred at room temperature for 12 hours, then diluted with dichloromethane and water. The aqueous phase is extracted three times with dichloromethane, the organic phases are combined and washed with a saturated solution of sodium hydrogen carbonate, with water and then with a saturated aqueous solution of sodium chloride. After drying over magnesium sulphate, the solution.", "anaphor": "the solution", "gold_antecedents": ["182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "105 mg (1 mmol) of 1-oxy-pyridin-2-ol", "a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide", "253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one", "0.15 mL (1 mmol) of triethylamine", "dichloromethane", "water", "dichloromethane", "a saturated solution of sodium hydrogen carbonate", "water", "a saturated aqueous solution of sodium chloride", "magnesium sulphate"], "preceding_anaphors": ["The reaction mixture", "The reaction mixture", "The aqueous phase", "the organic phases"]}
{"example_id": "0102-05", "context": "182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 105 mg (1 mmol) of 1-oxy-pyridin-2-ol are added to a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide. The reaction mixture is stirred for 5 min and then 253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one and 0.15 mL (1 mmol) of triethylamine are added. The reaction mixture is stirred at room temperature for 12 hours, then diluted with dichloromethane and water. The aqueous phase is extracted three times with dichloromethane, the organic phases are combined and washed with a saturated solution of sodium hydrogen carbonate, with water and then with a saturated aqueous solution of sodium chloride. After drying over magnesium sulphate, the solution is filtered and then concentrated under vacuum. After trituration of the crude residue in ethyl acetate.", "anaphor": "the crude residue in ethyl acetate", "gold_antecedents": ["182 mg (1 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "105 mg (1 mmol) of 1-oxy-pyridin-2-ol", "a solution of 320 mg (0.8 mmol) of [5-(2-chloro-3-fluorophenyl)-3-(2-methanesulphonyl-ethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid in 2 mL N,N-dimethylformamide", "253 mg (0.9 mmol) of 7-methylsulphanyl-3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one", "0.15 mL (1 mmol) of triethylamine", "dichloromethane", "water", "dichloromethane", "a saturated solution of sodium hydrogen carbonate", "water", "a saturated aqueous solution of sodium chloride", "magnesium sulphate"], "preceding_anaphors": ["The reaction mixture", "The reaction mixture", "The aqueous phase", "the organic phases", "the solution"]}
{"example_id": "1370-00", "context": "In the same manner as steps 4 and 5 of Example 53, Compound I-306 (66.9 mg, 0.117 mmol, 62% yield) was obtained as a yellow solid.", "anaphor": "a yellow solid", "gold_antecedents": ["Compound I-306 (66.9 mg, 0.117 mmol, 62% yield)"], "preceding_anaphors": []}
{"example_id": "1408-00", "context": "19.51 g of Compound 10 was prepared in the same manner as in Preparation Example 8, except that Compound A (10 g, 31.53 mmol) and N-([1,1'-biphenyl]-4-yl)-N-(4-bromophenyl)-[1,1'-biphenyl]-4-amine (11.48 g, 34.69 mmol) were used. (87%.", "anaphor": "87%", "gold_antecedents": ["Compound A (10 g, 31.53 mmol)", "N-([1,1'-biphenyl]-4-yl)-N-(4-bromophenyl)-[1,1'-biphenyl]-4-amine (11.48 g, 34.69 mmol)"], "preceding_anaphors": []}
